About the Journal

Pharmaceutical Novelty (PN) is a peer-reviewed, open-access scientific journal published by Borneo Novelty Publishing in collaboration with Politeknik Negeri Balikpapan. The journal is committed to the dissemination of innovative and high-quality research in the field of pharmaceutical sciences. It provides a platform for researchers, academics, practitioners, and students to publish original articles, reviews, and short communications that contribute to the advancement of pharmaceutical knowledge and practice.

Focus and Scope

Pharmaceutical Novelty covers a wide range of topics in pharmaceutical sciences, including but not limited to:

  • Drug discovery and development

  • Pharmaceutical technology and formulation

  • Novel drug delivery systems

  • Pharmacology and toxicology

  • Clinical and hospital pharmacy

  • Pharmacy practice and pharmacoeconomics

  • Natural products and herbal medicine

  • Regulatory affairs and pharmaceutical policy

The journal accepts manuscripts in the form of original research papers, literature reviews, short communications, and case reports that meet rigorous academic and ethical standards.

Open Access Policy

Pharmaceutical Novelty is an open-access journal, meaning that all articles are freely available to readers without subscription or access fees. This policy supports a greater global exchange of knowledge and ensures that research published in the journal can reach a broad audience. Authors retain copyright and articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing others to distribute and build upon the work with appropriate credit.

Peer Review Process

All manuscripts submitted to PN undergo a double-blind peer review process. This ensures that both authors and reviewers remain anonymous to each other, maintaining objectivity and academic integrity. Manuscripts are initially screened by the editorial board, and those meeting basic criteria are sent to at least two reviewers with expertise in the relevant field. Editorial decisions are based on the quality of the research, originality, clarity, and relevance to the journal’s scope.

Copyright Notice

Authors who publish in PN retain copyright over their work while granting the journal the right of first publication. All published articles are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0), which allows for unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited.

Sponsorship and Disclosure

Pharmaceutical Novelty is independently published by Borneo Novelty Publishing and currently does not receive financial sponsorship from any external organization. Any potential sponsorships, advertisements, or conflicts of interest will be disclosed transparently on the journal’s website to maintain editorial independence and uphold ethical standards.

History of the Journal

Pharmaceutical Novelty was established to respond to the increasing demand for a high-quality publication outlet in the pharmaceutical sciences. Since its inception, the journal has aimed to be a dynamic forum for scientific dialogue, emphasizing originality, scientific rigor, and relevance to the pharmaceutical profession.

Privacy Statement

The names, email addresses, and personal data submitted to this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party. The journal is committed to protecting the privacy of its users in accordance with international standards.

Archiving and Digital Preservation

Pharmaceutical Novelty uses the Open Journal Systems (OJS) platform which supports long-term preservation of published content. The journal is planned to be included in digital archiving systems such as LOCKSS (Lots of Copies Keep Stuff Safe) and CLOCKSS (Controlled LOCKSS), ensuring permanent availability and protection of the journal content.